NCT00332553

Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

Study of Vasomotor Symptoms in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 150 (planned)
• Sponsor: Eli Lilly and Company · Industry
• Sex: Female
• Age: 50 Years – 70 Years
• Healthy volunteers: Accepted

Summary

This pilot study was designed to explore the effects of combined treatment with raloxifene HCl 60 mg and oral 17 beta-estradiol 1mg/day on the number of vasomotor episodes (hot flashes plus night sweats) in postmenopausal women discontinuing continuous combined hormone replacement therapy (ccHRT) compared to women treated with raloxifene HCl 60 mg alone.

Conditions

• Vasomotor Symptoms
• Endometrial Safety

Interventions

Type	Name	Description
DRUG	Raloxifene
DRUG	medroxyprogesterone acetate
DRUG	estrogen
DRUG	17 beta estradiol

Timeline

• Start date: 2002-02-01
• Completion: 2004-05-01
• First posted: 2006-06-01
• Last updated: 2007-05-15

Locations

1 site across 1 country: United States